Forbes and other media are reporting on a massive insider trading deal involving Sidney Gilman of the University of Michigan Medical School, who allegedly gave information about an Alzheimer???s drug clinical trial to an investment portfolio manager ??? Matthew Martoma ??? prior to official release of the results.